DARUMA CAPITAL MANAGEMENT LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
DARUMA CAPITAL MANAGEMENT LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2014$3,200,000
-39.0%
24,276
-45.7%
0.13%
-41.7%
Q4 2013$5,248,000
+11.8%
44,702
-0.6%
0.22%
+1.4%
Q3 2013$4,692,000
+11.7%
44,968
-7.8%
0.22%
+4.9%
Q2 2013$4,199,00048,7830.20%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
Capital Analysts, LLC 7,350$439,309,0000.18%
GOLDMAN SACHS GROUP INC 2,996,127$179,078,0000.07%
MUFG Americas Holdings Corp 52,285$3,125,0000.06%
Zurcher Kantonalbank (Zurich Cantonalbank) 22,936$1,367,0000.05%
GOLDMAN SACHS GROUP INC 419,100$25,050,0000.01%
AQR Capital Management 35,829$2,141,0000.01%
HSBC HOLDINGS PLC 33,669$2,009,0000.01%
GOLDMAN SACHS GROUP INC 147,000$8,786,0000.00%
NOMURA HOLDINGS INC 6,000$359,0000.00%
Twin Tree Management, LP 455$27,0000.00%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders